You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
AbbVie said on Monday it would buy biotech Apogee Therapeutics for $10.9 billion, in more than five years.
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.